M. Zipfel

Most-cited papers

1. Cross-sectional increase of adherence to multidisciplinary tumor board decisions

   S. Hollunder, U. Herrlinger, M. Zipfel, J. Schmolders +14 more

   2018BMC Cancer58 citations Open access

   Semantic Scholar

   Save

2. Lung cancer screening with MRI: results of the first screening round

   M. Meier-Schroers, R. Homsi, D. Skowasch, J. Buermann +3 more

   2017Journal of Cancer Research and Clinical Oncology47 citations Open access

   Semantic Scholar

   Save

3. Phagocytic Activity and Oxidative Burst of Granulocytes in Persons with Myeloperoxidase Deficiency

   C. E. Gerber, S. Kuçi, M. Zipfel, D. Niethammer +1 more

   1996European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies38 citations Open access

   Semantic Scholar

   Save

4. Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108).

   K. Klinghammer, T. Gauler, A. Dietz, V. Grünwald +14 more

   2019European Journal of Cancer23 citations

   Semantic Scholar

   Save

5. A series of annexins from human placenta and their characterization by use of an endogenous phospholipase A2.

   W. Buhl, M. T. García, M. Zipfel, W. Schiebler +1 more

   1991European Journal of Cell Biology23 citations

   Semantic Scholar

   Save

6. Drug-related problems in head and neck cancer patients identified by repeated medication reviews on consecutive therapy cycles

   Corinna Vucur, Daniel A. Wirtz, L. Weinhold, M. Zipfel +3 more

   2020Journal of Oncology Pharmacy Practice7 citations

   Semantic Scholar

   Save

7. Cetuximab (C), fluorouracil (F), and cisplatin (P) alone or with docetaxel (D) for recurrent/metastatic (RM) head and neck cancer (HNSCC): First analysis of AIO trial # 1108.

   U. Keilholz, T. Gauler, A. Dietz, V. Gruenwald +13 more

   20145 citations

   Semantic Scholar

   Save

8. Mixed Response to Ipilimumab in a Melanoma Patient with Brain Metastases: Case Report and Review of the Literature

   G. Feldmann, P. Brossart, M. Zipfel, M. von Lilienfeld-Toal

   2013Case Reports in Oncology5 citations Open access

   Semantic Scholar

   Save

9. Membranes exert indirect negative control on phospholipase A2 in human placenta.

   W. Buhl, M. Zipfel, M. T. García, L. M. Eisenlohr +1 more

   1991Eicosanoids5 citations

   Semantic Scholar

   Save

10. 987OCETUXIMAB (C), FLUOROURACIL (F) AND CISPLATIN (P) ALONE OR WITH DOCETAXEL (D) FOR RECURRENT/METASTATIC (RM) HEAD AND NECK CANCER (HNSCC). FINAL ANALYSIS OF AIO TRIAL # 1108 - CEFCID.

    M. Knoedler, T. Gauler, A. Dietz, Viktor Grünwald +13 more

    2014Annals of Oncology4 citations Open access

    Semantic Scholar

    Save

11. Vasculitic leg ulcers in a patient with mixed myelodysplastic and myeloproliferative syndrome

    W. Hoetzenecker, M. Zipfel, E. Guenova, Konrad Hoetzenecker +1 more

    2007Journal of the European Academy of Dermatology and Venereology4 citations

    Semantic Scholar

    Save

12. Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial

    U. Goerling, T. Gauler, A. Dietz, V. Grünwald +13 more

    2021Oncology Research and Treatment2 citations Open access

    Semantic Scholar

    Save

13. Appearance of extraosseous pelvic Ewing sarcoma on triphasic bone scan.

    M. Muckle, E. Habibi, B. Simon, M. Zipfel +2 more

    2014Clinical Nuclear Medicine2 citations

    Semantic Scholar

    Save

14. Myeloperoxidase-Positive and Negative Granulocytes: Investigations by Flow Cytometry

    G. Bruchelt, C. E. Gerber, P. Bader, M. Zipfel +3 more

    20000 citations

    Semantic Scholar

    Save